OFI INVEST ASSET MANAGEMENT

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1977602 ISSY LES MOULINEAUX, I0

Position in VRTX

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$30,915,303

-$422,753 QoQ

Shares Held

69,233

+0.2% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

OFI INVEST ASSET MANAGEMENT holds $59,011,075 across 4 Biotechnology names. VRTX ranks #1 (52.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	69,233	$30,915,303
2	MRNA	Moderna, Inc.	547,881	$27,832,354
3	ALNY	Alnylam Pharmaceuticals, Inc.	729	$241,204
4	LEGN	Legend Biotech Corp	1,228	$22,214

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$30,915,303	69,233	+0.2%	Shares	Sole	2026-05-05
2025-12-31	$31,338,056	69,124	+23572.6%	Shares	Sole	2026-01-22
2025-09-30	$114,358	292	+36.4%	Shares	Sole	2025-10-14
2025-06-30	$95,272	214	-96.8%	Shares	Sole	2025-07-25
2025-03-31	$3,197,387	6,595	+6.4%	Shares	Sole	2025-05-09
2024-12-31	$2,495,129	6,196	+7645.0%	Shares	Sole	2025-02-07
2024-06-30	$37,497	80	+8.1%	Shares	Sole	2024-07-19
2024-03-31	$30,932	74	-1.3%	Shares	Sole	2024-04-29
2023-12-31	$30,516	75	-2.6%	Shares	Sole	2024-02-14
2023-09-30	$26,775	77	-100.0%	Shares	Sole	2023-11-02
2023-03-31	$58,469,430	185,576	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.